Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Pregnant patients with vs without connective tissue diseases faced increased risks for adverse maternal and fetal outcomes, including maternal death, preterm labor, and hypertensive disorders.

Get Instant Summarized Text (Gist) The first total synthesis of inaoside A, a compound from the mushroom Laetiporus cremeiporus, has been achieved. This synthesis, using α-selective Schmidt ...

Background: Connective tissue disorders (CTDs) are a heterogeneous group of ... myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), SH, gastroesophageal reflux disease (GERD), hypothyroidism, ...

High blood pressure affects multiple organs. Not only can hypertension add stress to the heart and damage arteries, leading to heart disease, but it also can cause strokes and kidney disease as ...